Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial
Marco Metra, Ewa A. Jankowska, Matteo Pagnesi, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1928-1939
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, et al.
The Lancet (2022) Vol. 400, Iss. 10369, pp. 2199-2209
Open Access | Times Cited: 239
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology
Marco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 6, pp. 776-791
Open Access | Times Cited: 95
Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis
Piotr Ponikowski, Robert J. Mentz, Adrian F. Hernandez, et al.
European Heart Journal (2023) Vol. 44, Iss. 48, pp. 5077-5091
Open Access | Times Cited: 79
Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis
Fraser J Graham, Pierpaolo Pellicori, Paul R. Kalra, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 4, pp. 528-537
Open Access | Times Cited: 74
2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 28
Predicting survival in patients with severe heart failure: Risk score validation in the HELP‐HF cohort
Mauro Chiarito, Davide Stolfo, Alessandro Villaschi, et al.
European Journal of Heart Failure (2025)
Open Access | Times Cited: 1
Heart failure: an update from the last years and a look at the near future
Mauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3667-3693
Open Access | Times Cited: 49
Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta‐analysis
Stefan D. Anker, Muhammad Shahzeb Khan, Javed Butler, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 1080-1090
Open Access | Times Cited: 36
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry
Daniela Tomasoni, Cristiana Vitale, Federica Guidetti, et al.
European Journal of Heart Failure (2023) Vol. 26, Iss. 4, pp. 854-868
Open Access | Times Cited: 22
Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis
Davor Vukadinović, Amr Abdin, Insa E. Emrich, et al.
Clinical Research in Cardiology (2023) Vol. 112, Iss. 7, pp. 954-966
Open Access | Times Cited: 21
Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1298-1312
Open Access | Times Cited: 3
Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING‐HF trial
Patricia Palau, Laura López, Eloy Domínguez, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 2, pp. 681-689
Open Access | Times Cited: 2
Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives
Francesco Corradi, G Masini, Tonino Bucciarelli, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 14, pp. 2405-2420
Closed Access | Times Cited: 7
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry
Alessandro Villaschi, Matteo Pagnesi, Davide Stolfo, et al.
The American Journal of Cardiology (2023) Vol. 204, pp. 268-275
Closed Access | Times Cited: 6
Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction
Hsiao-Ping Sung, Chien‐Yi Hsu, Ying‐Hsiang Lee, et al.
Journal of the Chinese Medical Association (2023) Vol. 86, Iss. 8, pp. 725-731
Open Access | Times Cited: 4
Iron deficiency in heart failure across the spectrum of left ventricular ejection fraction: dotting the i’s
Faro R. Verelst, Emeline M. Van Craenenbroeck, Andreas B. Gevaert
European Heart Journal (2023) Vol. 44, Iss. 16, pp. 1383-1385
Open Access | Times Cited: 3
Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials
Kirtipal Bhatia, Basera Sabharwal, Kartik Gupta, et al.
Journal of Cardiology (2023) Vol. 83, Iss. 2, pp. 105-112
Closed Access | Times Cited: 2
Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
Michał Tkaczyszyn, Marat Fudim, Piotr Ponikowski, et al.
Current Heart Failure Reports (2023) Vol. 20, Iss. 4, pp. 300-307
Open Access | Times Cited: 2
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond – major changes are coming
Giuliana Cimino, Edoardo Pancaldi, Daniela Tomasoni, et al.
Journal of Cardiovascular Medicine (2022) Vol. 23, Iss. 12, pp. 761-769
Closed Access | Times Cited: 4
A PROSPECTIVE STUDY ON CHARACTERIZATION OF IRON DEFICIENCY IN PATIENTS WITH CHRONIC HEART FAILURE
Kamran M. Riaz, Asmara Ali, Muhammad Ammar, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2024), pp. 1449-1455
Open Access
Mitral Regurgitation in Heart Failure
Matteo Pagnesi
(2024)
Open Access
The HF-ABCDE + FG approach in heart failure: a simplified decision-making algorithm for management in emergency department
Giuseppe Pepe, Martina Vignani, Giancarlo Casolo, et al.
European Heart Journal Acute Cardiovascular Care (2023) Vol. 13, Iss. 2, pp. 242-244
Closed Access | Times Cited: 1
December 2023 at a glance: Focus on medical therapy in chronic and acute heart failure
Daniela Tomasoni, Marianna Adamo, Marco Metra
European Journal of Heart Failure (2023) Vol. 25, Iss. 12, pp. 2099-2101
Closed Access | Times Cited: 1
Increases in Fibroblast Growth Factor 23 During Treatment With Ferric Carboxymaltose: Potential Adverse Effects on the Heart and Kidneys
Milton Packer
Journal of Cardiac Failure (2022) Vol. 29, Iss. 2, pp. 229-231
Closed Access | Times Cited: 1
Corrigendum to: ‘An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum’ and articles listed below

European Journal of Heart Failure (2023) Vol. 25, Iss. 3, pp. 444-444
Open Access
Page 1 - Next Page

Scroll to top